Evolve Global Healthcare Stock Profit Margin
| LIFE Stock | CAD 21.67 0.05 0.23% |
Evolve Global Healthcare fundamentals help investors to digest information that contributes to Evolve Global's financial success or failures. It also enables traders to predict the movement of Evolve Stock. The fundamental analysis module provides a way to measure Evolve Global's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evolve Global stock.
Evolve |
Evolve Global Healthcare Company Profit Margin Analysis
Evolve Global's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Evolve Global Healthcare has a Profit Margin of 0.0%. This is 100.0% lower than that of the Oil, Gas & Consumable Fuels sector and about the same as Energy (which currently averages 0.0) industry. The profit margin for all Canada stocks is 100.0% lower than that of the firm.
Evolve Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evolve Global's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evolve Global could also be used in its relative valuation, which is a method of valuing Evolve Global by comparing valuation metrics of similar companies.Evolve Global is currently under evaluation in profit margin category among its peers.
Fund Asset Allocation for Evolve Global
The fund invests 60.86% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides Evolve Global's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Evolve Fundamentals
| Beta | 0.71 | ||||
| Total Asset | 4 M | ||||
| Annual Yield | 0.09 % | ||||
| One Year Return | 11.01 % | ||||
| Net Asset | 4 M | ||||
| Last Dividend Paid | 0.12 | ||||
| Equity Positions Weight | 60.86 % |
About Evolve Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evolve Global Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolve Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolve Global Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Evolve Stock
Evolve Global financial ratios help investors to determine whether Evolve Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolve with respect to the benefits of owning Evolve Global security.